Anyone taking medications or managing a metabolic condition should get a medical evaluation before relying on a patch instead of supervised care
The STEP clinical trial program, which evaluated higher doses of semaglutide (2.4 mg weekly) for chronic weight management, demonstrated significantly higher rates of vomiting, with approximately 20-25% of participants reporting this adverse effect during the study period
Advise pregnant women of the potential risk to a fetus
Prescription medication is available only after a licensed healthcare provider determines it's clinically appropriate - approval is not guaranteed
Weight Loss Benefits Though semaglutide is officially approved for treating diabetes, doctors often prescribe it to help with weight loss too
Zinc transporters Therapeutic potential of zinc transporters in carcinogenesis Zinc transporters not only contribute significantly to the onset and progression of cancer, but they are also implicated in the development of both chemoresistance and radiotherapy resistance